iExposure Intervention for Social Anxiety
Running, not enrolling · Not applicable
Conditions studied: Social Anxiety
In brief
Social anxiety (SA) is a highly prevalent mental health concern, thought to disproportionately affect youth with recent international estimates of more than 30% of individuals reporting clinically elevated symptoms. Despite the prevalence of SA, as few as one in five individuals receive care, due to limited access to evidence-based treatments. Additionally there has been a notable increase in social anxiety since the start of the COVID-19 pandemic. This proposal will use iExposure to develop a personalized mechanism-focused approach to optimizing treatment response for individuals with social anxiety by testing standard iExposure against two augmentations that incorporate distinct attention mechanisms (attention guidance and attention control).
Key facts
- Study ID
- NCT06409247
- Run by
- Palo Alto University
- People needed
- 390
- Starts
- 2024-07-01
- Expected to finish
- 2026-03-30
- Last updated by the study team
- 2026-03-09
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age 18 or older
- Fluent in English
- Leibowitz Social Anxiety Scale > 47 and endorses both social anxiety items on the Web Screening Questionnaire for Common Mental Disorders
You may not qualify if…
- Currently receiving CBT for Social Anxiety Disorder
- Significant visual impairment precluding engagement in the simulated teleconferencing interactions
- Unstable dose of psychotropic medications within 6 weeks prior to baseline assessment
- Current alcohol or substance use disorder
- Current or past bipolar disorder or psychosis
Where it is running
- Palo Alto University — Palo Alto, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.